BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10688671)

  • 41. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
    Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
    J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
    Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
    Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MTB, the murine homolog of condensin II subunit CAP-G2, represses transcription and promotes erythroid cell differentiation.
    Xu Y; Leung CG; Lee DC; Kennedy BK; Crispino JD
    Leukemia; 2006 Jul; 20(7):1261-9. PubMed ID: 16673016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
    Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
    J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
    Cheng JT; Hsu HL; Hwang LY; Baer R
    Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
    Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
    Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
    Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
    Hsu HL; Wadman I; Baer R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis.
    Ravet E; Reynaud D; Titeux M; Izac B; Fichelson S; Roméo PH; Dubart-Kupperschmitt A; Pflumio F
    Blood; 2004 May; 103(9):3326-35. PubMed ID: 14715640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells.
    Tang T; Arbiser JL; Brandt SJ
    J Biol Chem; 2002 May; 277(21):18365-72. PubMed ID: 11904294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.
    Imai Y; Kurokawa M; Yamaguchi Y; Izutsu K; Nitta E; Mitani K; Satake M; Noda T; Ito Y; Hirai H
    Mol Cell Biol; 2004 Feb; 24(3):1033-43. PubMed ID: 14729951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gradient of E2A activity in B-cell development.
    Herblot S; Aplan PD; Hoang T
    Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A.
    Eilers AL; Billin AN; Liu J; Ayer DE
    J Biol Chem; 1999 Nov; 274(46):32750-6. PubMed ID: 10551834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.
    Dey S; Curtis DJ; Jane SM; Brandt SJ
    Mol Cell Biol; 2010 May; 30(9):2181-92. PubMed ID: 20194619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.
    Sjöblom-Hallén A; Yang W; Jansson A; Rymo L
    J Virol; 1999 Apr; 73(4):2983-93. PubMed ID: 10074148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repression of p53-mediated transcription by adenovirus E1B 55-kDa does not require corepressor mSin3A and histone deacetylases.
    Zhao LY; Santiago A; Liu J; Liao D
    J Biol Chem; 2007 Mar; 282(10):7001-10. PubMed ID: 17209038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene.
    Clem BF; Clark BJ
    Mol Endocrinol; 2006 Jan; 20(1):100-13. PubMed ID: 16109738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
    Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
    Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.